American Society of Clinical Oncology

Latest stories

4h
TribLIVE
Newsmaker: Diwakar Davar, MD | TribLIVE Diwakar Davar, MD, 34, of Highland Park, is being recognized by th
Newsmaker: Diwakar Davar, MD
TribLIVE / Posted 4 hours ago
| TribLIVE Diwakar Davar, MD, 34, of Highland Park, is being recognized by the American Society of Clinical Oncology with a Young Investigator Award. The organization is providing Davar $50K to fund his research into... Read more
1d
Business Standard India
Biocon: Positives factored infrom global confirmatory efficacy and safety study with Trastuzumab, the breast
Biocon: Positives factored in
Business Standard India / Posted yesterday
from global confirmatory efficacy and safety study with Trastuzumab, the breast cancer drug, was also presented at the American Society of Clinical Oncology. Biocon already had initiated Phase III clinical trials of biosimilars such as... Read more
3d
Business Wire
IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Immunomedics Inc.include, but are not limited to, that: (i) IMMU’s abstract for its cancer-treat
IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Immunomedics Inc.
Business Wire / Posted 3 days ago
include, but are not limited to, that: (i) IMMU’s abstract for its cancer-treatment drug IMMU-132 submitted to the American Society of Clinical Oncology (“ASCO”) for presentation at the 2016 ASCO Annual Meeting contained previously... Read more
4d
Business Wire
Puma Biotechnology Announces Interim 5-Year Disease Free Survival Data from Phase III Trial of PB272 (Neratinib) in Extended Adjuvant HER2-Positive Early Stage Breast Cancer (ExteNET Trial)93.9% and the 2-year invasive DFS rate for the placebo arm was 91.6%. These res
Puma Biotechnology Announces Interim 5-Year Disease Free Survival Data from Phase III Trial of PB272 (Neratinib) in Extended Adjuvant HER2-Positive Early Stage Breast Cancer (ExteNET Trial)
Business Wire / Posted 4 days ago
93.9% and the 2-year invasive DFS rate for the placebo arm was 91.6%. These results were previously reported at the 2015 American Society of Clinical Oncology meeting and updated results, including interim 3-year invasive DFS data, were presented... Read more
6d
Business Wire
Synaffix Achieves Significantly Improved Therapeutic Index Compared to Both FDA-Approved ADCs and Expands Its Scientific Advisory Boardof Dr. George W. Sledge, the Chief of Medical Oncology at Stanford University M
Synaffix Achieves Significantly Improved Therapeutic Index Compared to Both FDA-Approved ADCs and Expands Its Scientific Advisory Board
Business Wire / Posted 6 days ago
of Dr. George W. Sledge, the Chief of Medical Oncology at Stanford University Medical Center and former President of the American Society of Clinical Oncology. “It is an honor to join the SAB at such an important time in the Company’s history.... Read more
10d
Business Wire
Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016to investors and/or failed to disclose that: (1) the Company’s abstract for ant
Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016
Business Wire / Posted 10 days ago
to investors and/or failed to disclose that: (1) the Company’s abstract for antibody-drug IMMU-132 submitted to the American Society of Clinical Oncology (“ASCO”) for presentation at the 2016 ASCO Annual Meeting contained previously... Read more
13d
Hawaii News Now
Obit-Knudson storyof genes in the cell that could function to stop abnormal cell growths, which a
Obit-Knudson story
Hawaii News Now / Posted 13 days ago
of genes in the cell that could function to stop abnormal cell growths, which are now called tumor suppressor genes. The American Society of Clinical Oncology called Knudson "a pioneering cancer geneticist" and credited him with "helping to usher... Read more
7 related stories
13d
FOX News
Organizations issue joint guidelines for breast cancer survivorsjoint guidelines from two leading U.S. cancer groups. The guidelines issued to
Organizations issue joint guidelines for breast cancer survivors
FOX News / Posted 13 days ago
joint guidelines from two leading U.S. cancer groups. The guidelines issued today by the American Cancer Society and the American Society of Clinical Oncology (ASCO) provide an updated road map to help women and their primary care doctors... Read more
13d
Northwest Herald
Doctors urging use of HPV vaccineconsensus statement saying the HPV vaccine was “tragically underused” and calli
Doctors urging use of HPV vaccine
Northwest Herald / Posted 13 days ago
consensus statement saying the HPV vaccine was “tragically underused” and calling on doctors to strongly recommend it. The American Society of Clinical Oncology followed with a similar statement. Cancer doctors have been reaching out to... Read more
14d
The Hendersonville Times-News
Famed cancer theorist Dr. Alfred G. Knudson Jr. dies at 93of genes in the cell that could function to stop abnormal cell growths, which a
Famed cancer theorist Dr. Alfred G. Knudson Jr. dies at 93
The Hendersonville Times-News / Posted 14 days ago
of genes in the cell that could function to stop abnormal cell growths, which are now called tumor suppressor genes. The American Society of Clinical Oncology called Knudson "a pioneering cancer geneticist" and credited him with "helping to usher... Read more
7 related stories
14d
The Lexington Dispatch
Famed cancer theorist Dr. Alfred G. Knudson Jr. dies at 93of genes in the cell that could function to stop abnormal cell growths, which a
Famed cancer theorist Dr. Alfred G. Knudson Jr. dies at 93
The Lexington Dispatch / Posted 14 days ago
of genes in the cell that could function to stop abnormal cell growths, which are now called tumor suppressor genes. The American Society of Clinical Oncology called Knudson "a pioneering cancer geneticist" and credited him with "helping to usher... Read more
7 related stories
14d
Hawaii News Now
Famed cancer theorist Dr. Alfred G. Knudson Jr. dies at 93of genes in the cell that could function to stop abnormal cell growths, which a
Famed cancer theorist Dr. Alfred G. Knudson Jr. dies at 93
Hawaii News Now / Posted 14 days ago
of genes in the cell that could function to stop abnormal cell growths, which are now called tumor suppressor genes. The American Society of Clinical Oncology called Knudson "a pioneering cancer geneticist" and credited him with "helping to usher... Read more
7 related stories
14d
Salon.com
Famed cancer theorist Dr. Alfred G. Knudson Jr. dies at 93of genes in the cell that could function to stop abnormal cell growths, which a
Famed cancer theorist Dr. Alfred G. Knudson Jr. dies at 93
Salon.com / Posted 14 days ago
of genes in the cell that could function to stop abnormal cell growths, which are now called tumor suppressor genes. The American Society of Clinical Oncology called Knudson “a pioneering cancer geneticist” and credited him with “helping to usher... Read more
7 related stories
14d
Spartanburg Herald-Journal
Famed cancer theorist Dr. Alfred G. Knudson Jr. dies at 93of genes in the cell that could function to stop abnormal cell growths, which a
Famed cancer theorist Dr. Alfred G. Knudson Jr. dies at 93
Spartanburg Herald-Journal / Posted 14 days ago
of genes in the cell that could function to stop abnormal cell growths, which are now called tumor suppressor genes. The American Society of Clinical Oncology called Knudson "a pioneering cancer geneticist" and credited him with "helping to usher... Read more
7 related stories
14d
ABC News
Famed Cancer Theorist Dr. Alfred G. Knudson Jr. Dies at 93of genes in the cell that could function to stop abnormal cell growths, which a
Famed Cancer Theorist Dr. Alfred G. Knudson Jr. Dies at 93
ABC News / Posted 14 days ago
of genes in the cell that could function to stop abnormal cell growths, which are now called tumor suppressor genes. The American Society of Clinical Oncology called Knudson "a pioneering cancer geneticist" and credited him with "helping to usher... Read more
7 related stories
15d
Japan Today
Breast cancer survivors not always clear about follow-up care ‹ Japan TodayBreast cancer survivors may not always realize why follow-up care is important,
Breast cancer survivors not always clear about follow-up care ‹ Japan Today
Japan Today / Posted 15 days ago
Breast cancer survivors may not always realize why follow-up care is important, a small study suggests. According to the American Society of Clinical Oncology, the purpose of follow up care is to keep patients in good health, manage side effects... Read more
16d
Business Wire
UPCOMING DEADLINE ALERT - Immunomedics, Inc. - Brower Piven Reminds Shareholders of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess of $100,000 To Contact The Firmabstract for the antibody-drug, conjugate sacituzumab govitecan IMMU-132 (“IMMU
UPCOMING DEADLINE ALERT - Immunomedics, Inc. - Brower Piven Reminds Shareholders of Approaching Deadline In Class Action Lawsuit And Encourages Investors Who Have Losses In Excess of $100,000 To Contact The Firm
Business Wire / Posted 16 days ago
abstract for the antibody-drug, conjugate sacituzumab govitecan IMMU-132 (“IMMU-132”), that Immunomedics submitted to the American Society of Clinical Oncology (“ASCO”) for presentation at the 2016 ASCO Annual Meeting, contained previously... Read more
2 related stories
18d
FOX News
Promising drugs stoke talk of eventual cancer 'cure'and drug company executives said in interviews with Reuters. But as they gathe
Promising drugs stoke talk of eventual cancer 'cure'
FOX News / Posted 18 days ago
and drug company executives said in interviews with Reuters. But as they gather Friday at the annual meeting of American Society of Clinical Oncology in Chicago, a new optimism is expected to permeate many conversations. Talking about... Read more
20d
Newsmax
Breast Cancer Survivors Sometimes Unsure About Follow Up CareAccording to the American Society of Clinical Oncology, the purpose of follow u
Breast Cancer Survivors Sometimes Unsure About Follow Up Care
Newsmax / Posted 20 days ago
According to the American Society of Clinical Oncology, the purpose of follow up care is to keep patients in good health, manage side effects from treatment, find out if cancer has returned, and screen for other types of cancer, along with providing... Read more
3 related stories
20d
FOX News
Breast cancer survivors not always clear about follow up careBreast cancer survivors may not always realize why follow-up care is important,
Breast cancer survivors not always clear about follow up care
FOX News / Posted 20 days ago
Breast cancer survivors may not always realize why follow-up care is important, a small study suggests. According to the American Society of Clinical Oncology, the purpose of follow up care is to keep patients in good health, manage side effects... Read more
3 related stories
21d
Decclan Chronicle
Breast cancer survivors not always clear about follow up careBreast cancer survivors may not always realize why follow-up care is important,
Breast cancer survivors not always clear about follow up care
Decclan Chronicle / Posted 21 days ago
Breast cancer survivors may not always realize why follow-up care is important, a small study suggests. According to the American Society of Clinical Oncology, the purpose of follow up care is to keep patients in good health, manage side effects... Read more
3 related stories
21d
The Globe and Mail
Breast cancer survivors not always clear about follow-up careBreast cancer survivors may not always realize why follow-up care is important,
Breast cancer survivors not always clear about follow-up care
The Globe and Mail / Posted 21 days ago
Breast cancer survivors may not always realize why follow-up care is important, a small study suggests. According to the American Society of Clinical Oncology, the purpose of follow up care is to keep patients in good health, manage side effects... Read more
3 related stories
24d
Business Wire
Goldberg Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. and Encourages Investors With Losses to Contact the Firmstatements to investors and/or failed to disclose: that the Company’s abstract
Goldberg Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. and Encourages Investors With Losses to Contact the Firm
Business Wire / Posted 24 days ago
statements to investors and/or failed to disclose: that the Company’s abstract for antibody-drug IMMU-132 submitted to the American Society of Clinical Oncology (ASCO) for presentation at their 2016 Annual Meeting contained previously disclosed... Read more
9 related stories
27d
The Norwich Bulletin
Doctors urging use of HPV vaccineconsensus statement saying the HPV vaccine was "tragically underused" and calli
Doctors urging use of HPV vaccine
The Norwich Bulletin / Posted 27 days ago
consensus statement saying the HPV vaccine was "tragically underused" and calling on doctors to strongly recommend it. The American Society of Clinical Oncology followed with a similar statement.Cancer doctors have been reaching out to primary-care... Read more
m
Business Wire
Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firmstatements to investors and/or failed to disclose: that the Company’s abstract
Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firm
Business Wire / Posted 1 months ago
statements to investors and/or failed to disclose: that the Company’s abstract for antibody-drug IMMU-132 submitted to the American Society of Clinical Oncology (ASCO) for presentation at their 2016 Annual Meeting contained previously disclosed... Read more
24 related stories
m
Fortune
How Blood Testing Technology Got So Hotfirst-of-its-kind blood test to assess the efficacy of its lung cancer drug, Ta
How Blood Testing Technology Got So Hot
Fortune / Posted 1 months ago
first-of-its-kind blood test to assess the efficacy of its lung cancer drug, Tarceva, for different patients. And at June’s American Society of Clinical Oncology annual meeting, Guardant Health unveiled a trove of data showing that its blood-testing... Read more

People in this news